Cargando…
N-methyl-D-aspartate receptor blockers attenuate bleomycin-induced pulmonary fibrosis by inhibiting endogenous mesenchymal stem cells senescence
BACKGROUND: A large number of our previous studies showed that endogenous glutamate and N-methyl-D-aspartate receptor (NMDAR) activation may be involved in various types of acute lung injury, airway inflammation, asthma, and pulmonary fibrosis. In animal models, the transplantation of exogenous bone...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263776/ https://www.ncbi.nlm.nih.gov/pubmed/35813315 http://dx.doi.org/10.21037/atm-22-2507 |
_version_ | 1784742820962107392 |
---|---|
author | Huang, Pu Zhou, Yan Li, Xiao-Hong Zhang, Yun-Na Cheng, Hai-Peng Fu, Jia-Feng Liu, Wei Yue, Shaojie Luo, Zi-Qiang |
author_facet | Huang, Pu Zhou, Yan Li, Xiao-Hong Zhang, Yun-Na Cheng, Hai-Peng Fu, Jia-Feng Liu, Wei Yue, Shaojie Luo, Zi-Qiang |
author_sort | Huang, Pu |
collection | PubMed |
description | BACKGROUND: A large number of our previous studies showed that endogenous glutamate and N-methyl-D-aspartate receptor (NMDAR) activation may be involved in various types of acute lung injury, airway inflammation, asthma, and pulmonary fibrosis. In animal models, the transplantation of exogenous bone marrow mesenchymal stem cells (BM-MSCs) is the most promising treatment for idiopathic pulmonary fibrosis. However, there are limited reports on the status of endogenous BM-MSCs in the process of bleomycin-induced pulmonary fibrosis in animals. METHODS: We constructed a mouse model of bleomycin-induced pulmonary fibrosis. In vitro, the senescence model of BM-MSCs was constructed with hydrogen peroxide and high concentration of N-methyl-D-aspartate (NDMA). The changes in aging-related indexes were detected by senescence associated beta-galactosidase (SA-β-gal) staining, western blot, flow cytometry and real time-PCR. The epithelial-mesenchymal transformation (EMT) changes of mouse lung epithelial cells (MLE-12) co-cultured with senescent BM-MSCs were detected by immunofluorescence and western blotting. RESULTS: We observed that endogenous BM-MSCs senescence occurs during bleomycin-induced pulmonary fibrosis in mice, and the model group had a higher expression level of the NMDAR subunit than the control group. We observed a significant increase in NMDAR subunit expression in a hydrogen peroxide-induced senescent cell model in vitro. BM-MSCs showed senescence-related phenotype and cell cycle arrest after high concentration of NMDA treatment. At the same time, the expression levels of the classic Wingless and int-1 (Wnt) pathway protein β-cantenin and downstream cyclin D1 also changed. In the co-culture of aged BM-MSCs and MLE-12 cells, EMT can be promoted in MLE-12 cells, and MK-801 can partially antagonize the occurrence of EMT. The NMDAR antagonist can partially prevent the above phenomenon. CONCLUSIONS: High concentrations of NMDA can promote senescence of BM-MSCs. NMDAR blockers may inhibit endogenous BM-MSCs aging through the WNT signaling pathway, thereby reducing the effect of bleomycin-induced pulmonary fibrosis. |
format | Online Article Text |
id | pubmed-9263776 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-92637762022-07-09 N-methyl-D-aspartate receptor blockers attenuate bleomycin-induced pulmonary fibrosis by inhibiting endogenous mesenchymal stem cells senescence Huang, Pu Zhou, Yan Li, Xiao-Hong Zhang, Yun-Na Cheng, Hai-Peng Fu, Jia-Feng Liu, Wei Yue, Shaojie Luo, Zi-Qiang Ann Transl Med Original Article BACKGROUND: A large number of our previous studies showed that endogenous glutamate and N-methyl-D-aspartate receptor (NMDAR) activation may be involved in various types of acute lung injury, airway inflammation, asthma, and pulmonary fibrosis. In animal models, the transplantation of exogenous bone marrow mesenchymal stem cells (BM-MSCs) is the most promising treatment for idiopathic pulmonary fibrosis. However, there are limited reports on the status of endogenous BM-MSCs in the process of bleomycin-induced pulmonary fibrosis in animals. METHODS: We constructed a mouse model of bleomycin-induced pulmonary fibrosis. In vitro, the senescence model of BM-MSCs was constructed with hydrogen peroxide and high concentration of N-methyl-D-aspartate (NDMA). The changes in aging-related indexes were detected by senescence associated beta-galactosidase (SA-β-gal) staining, western blot, flow cytometry and real time-PCR. The epithelial-mesenchymal transformation (EMT) changes of mouse lung epithelial cells (MLE-12) co-cultured with senescent BM-MSCs were detected by immunofluorescence and western blotting. RESULTS: We observed that endogenous BM-MSCs senescence occurs during bleomycin-induced pulmonary fibrosis in mice, and the model group had a higher expression level of the NMDAR subunit than the control group. We observed a significant increase in NMDAR subunit expression in a hydrogen peroxide-induced senescent cell model in vitro. BM-MSCs showed senescence-related phenotype and cell cycle arrest after high concentration of NMDA treatment. At the same time, the expression levels of the classic Wingless and int-1 (Wnt) pathway protein β-cantenin and downstream cyclin D1 also changed. In the co-culture of aged BM-MSCs and MLE-12 cells, EMT can be promoted in MLE-12 cells, and MK-801 can partially antagonize the occurrence of EMT. The NMDAR antagonist can partially prevent the above phenomenon. CONCLUSIONS: High concentrations of NMDA can promote senescence of BM-MSCs. NMDAR blockers may inhibit endogenous BM-MSCs aging through the WNT signaling pathway, thereby reducing the effect of bleomycin-induced pulmonary fibrosis. AME Publishing Company 2022-06 /pmc/articles/PMC9263776/ /pubmed/35813315 http://dx.doi.org/10.21037/atm-22-2507 Text en 2022 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Original Article Huang, Pu Zhou, Yan Li, Xiao-Hong Zhang, Yun-Na Cheng, Hai-Peng Fu, Jia-Feng Liu, Wei Yue, Shaojie Luo, Zi-Qiang N-methyl-D-aspartate receptor blockers attenuate bleomycin-induced pulmonary fibrosis by inhibiting endogenous mesenchymal stem cells senescence |
title | N-methyl-D-aspartate receptor blockers attenuate bleomycin-induced pulmonary fibrosis by inhibiting endogenous mesenchymal stem cells senescence |
title_full | N-methyl-D-aspartate receptor blockers attenuate bleomycin-induced pulmonary fibrosis by inhibiting endogenous mesenchymal stem cells senescence |
title_fullStr | N-methyl-D-aspartate receptor blockers attenuate bleomycin-induced pulmonary fibrosis by inhibiting endogenous mesenchymal stem cells senescence |
title_full_unstemmed | N-methyl-D-aspartate receptor blockers attenuate bleomycin-induced pulmonary fibrosis by inhibiting endogenous mesenchymal stem cells senescence |
title_short | N-methyl-D-aspartate receptor blockers attenuate bleomycin-induced pulmonary fibrosis by inhibiting endogenous mesenchymal stem cells senescence |
title_sort | n-methyl-d-aspartate receptor blockers attenuate bleomycin-induced pulmonary fibrosis by inhibiting endogenous mesenchymal stem cells senescence |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263776/ https://www.ncbi.nlm.nih.gov/pubmed/35813315 http://dx.doi.org/10.21037/atm-22-2507 |
work_keys_str_mv | AT huangpu nmethyldaspartatereceptorblockersattenuatebleomycininducedpulmonaryfibrosisbyinhibitingendogenousmesenchymalstemcellssenescence AT zhouyan nmethyldaspartatereceptorblockersattenuatebleomycininducedpulmonaryfibrosisbyinhibitingendogenousmesenchymalstemcellssenescence AT lixiaohong nmethyldaspartatereceptorblockersattenuatebleomycininducedpulmonaryfibrosisbyinhibitingendogenousmesenchymalstemcellssenescence AT zhangyunna nmethyldaspartatereceptorblockersattenuatebleomycininducedpulmonaryfibrosisbyinhibitingendogenousmesenchymalstemcellssenescence AT chenghaipeng nmethyldaspartatereceptorblockersattenuatebleomycininducedpulmonaryfibrosisbyinhibitingendogenousmesenchymalstemcellssenescence AT fujiafeng nmethyldaspartatereceptorblockersattenuatebleomycininducedpulmonaryfibrosisbyinhibitingendogenousmesenchymalstemcellssenescence AT liuwei nmethyldaspartatereceptorblockersattenuatebleomycininducedpulmonaryfibrosisbyinhibitingendogenousmesenchymalstemcellssenescence AT yueshaojie nmethyldaspartatereceptorblockersattenuatebleomycininducedpulmonaryfibrosisbyinhibitingendogenousmesenchymalstemcellssenescence AT luoziqiang nmethyldaspartatereceptorblockersattenuatebleomycininducedpulmonaryfibrosisbyinhibitingendogenousmesenchymalstemcellssenescence |